Targeting toll-like receptor 7 as a therapeutic development strategy for systemic lupus erythematosus.
Wang M, Chen H, Zhang T, Zhang Z, Xiang X, Gao M, Guo Y, Jiang S, Yin K, Chen M, Huang J, Zhong X, Ohto U, Li J, Shimizu T, Yin H.
Wang M, et al. Among authors: guo y.
Acta Pharm Sin B. 2024 Nov;14(11):4899-4913. doi: 10.1016/j.apsb.2024.08.016. Epub 2024 Aug 27.
Acta Pharm Sin B. 2024.
PMID: 39664432
Free PMC article.